Skip to main content
SpringerLink
Log in

Urine Cytology

  • Chapter
  • First Online:
Urinary Bladder Pathology

  • 794 Accesses

Abstract

Urine cytology plays a key role in bladder cancer screening, diagnosis, and surveillance. Although it has a high specificity of diagnosing high-grade urothelial carcinoma, the sensitivity of urine cytology is low, especially for low-grade lesions. Benign reactive changes can complicate cytology interpretation with diagnostic pitfalls. Urine cytology should be practiced in the context of patient history, and non-urothelial primary and bladder involvement of secondary tumors should be differentiated. Ancillary testing is important to the urine cytology diagnosis. This chapter will review urine cytology indications, diagnostic categories, The Paris System of reporting, and ancillary testing, as well as discuss diagnostic challenges and pitfalls.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Papanicolaou GN, Marshall VF. Urine sediment smears as a diagnostic procedure in cancers of the urinary tract. Science. 1945;101(2629):519–20.

    Google Scholar 

  2. Ooms EC, Veldhuizen RW. Cytological criteria and diagnostic terminology in urinary cytology. Cytopathology. 1993;4(1):51–4.

    Google Scholar 

  3. Fracchia JA, Motta J, Miller LS, Armenakas NA, Schumann GB, Greenberg RA. Evaluation of asymptomatic microhematuria. Urology. 1995;46(4):484–9.

    Google Scholar 

  4. Potts SA, Thomas PA, Cohen MB, Raab SS. Diagnostic accuracy and key cytologic features of high-grade transitional cell carcinoma in the upper urinary tract. Mod Pathol. 1997;10(7):657–62.

    Google Scholar 

  5. Smith ZL, Christodouleas JP, Keefe SM, Malkowicz SB, Guzzo TJ. Bladder preservation in the treatment of muscle-invasive bladder cancer (MIBC): a review of the literature and a practical approach to therapy. BJU Int. 2013;112(1):13–25.

    Google Scholar 

  6. Têtu B. Diagnosis of urothelial carcinoma from urine. Mod Pathol. 2009;22 Suppl 2:S53–9.

    Google Scholar 

  7. Nasuti JF, Gomella LG, Ismial M, Bibbo M. Utility of the BTA stat test kit for bladder cancer screening. Diagn Cytopathol. 1999;21(1):27–9.

    Google Scholar 

  8. Zhang ML, Rosenthal DL, VandenBussche CJ. The cytomorphological features of low-grade urothelial neoplasms vary by specimen type. Cancer Cytopathol. 2016;124(8):552–64.

    Google Scholar 

  9. McCroskey Z, Pambuccian SE, Kleitherms S, Antic T, Cohen MB, Barkan GA, et al. Accuracy and interobserver variability of the cytologic diagnosis of low-grade urothelial carcinoma in instrumented urinary tract cytology specimens. Am J Clin Pathol. 2015;144(6):902–8.

    Google Scholar 

  10. Amin MB, Smith SC, Reuter VE, Epstein JI, Grignon DJ, Hansel DE, et al. Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer. Mod Pathol. 2015;28(5):612–30.

    Google Scholar 

  11. Barkan GA, Wojcik EM, Nayar R, Savic-Prince S, Quek ML, Kurtycz DF, et al. The Paris System for Reporting Urinary Cytology: The Quest to Develop a Standardized Terminology. Acta Cytol. 2016;60(3):185-97. Barkan GA, Wojcik EM, Nayar R, Savic-Prince S, Quek ML, Kurtycz DF, et al. The Paris System for Reporting Urinary Cytology: The Quest to Develop a Standardized Terminology. Acta Cytol. 2016;60(3):185–97.

    Google Scholar 

  12. Owens CL, Vandenbussche CJ, Burroughs FH, Rosenthal DL. A review of reporting systems and terminology for urine cytology. Cancer Cytopathol. 2013;121(1):9–14.

    Google Scholar 

  13. Matzkin H, Moinuddin SM, Soloway MS. Value of urine cytology versus bladder washing in bladder cancer. Urology. 1992;39(3):201–3.

    Google Scholar 

  14. Bian Y, Ehya H, Bagley DH. Cytologic diagnosis of upper urinary tract neoplasms by ureteroscopic sampling. Acta Cytol. 1995;39(4):733–40.

    Google Scholar 

  15. Reynolds JP, Voss JS, Kipp BR, Karnes RJ, Nassar A, Clayton AC, et al. Comparison of urine cytology and fluorescence in situ hybridization in upper urothelial tract samples. Cancer Cytopathol. 2014;122(6):459–67.

    Google Scholar 

  16. Yoshimine S, Kikuchi E, Matsumoto K, Ide H, Miyajima A, Nakagawa K, et al. The clinical significance of urine cytology after a radical cystectomy for urothelial cancer. Int J Urol. 2010;17(6):527–32.

    Google Scholar 

  17. Layfield LJ, Elsheikh TM, Fili A, Nayar R, Shidham V. Review of the state of the art and recommendations of the Papanicolaou Society of Cytopathology for urinary cytology procedures and reporting : the Papanicolaou Society of Cytopathology Practice Guidelines Task Force. Diagn Cytopathol. 2004;30(1):24–30.

    Google Scholar 

  18. VandenBussche CJ, Rosenthal DL, Olson MT. Adequacy in voided urine cytology specimens: The role of volume and a repeat void upon predictive values for high-grade urothelial carcinoma. Cancer Cytopathol. 2016;124(3):174–80.

    Google Scholar 

  19. Prather J, Arville B, Chatt G, Pambuccian SE, Wojcik EM, Quek ML, et al. Evidence-based adequacy criteria for urinary bladder barbotage cytology. J Am Soc Cytopathol. 2015;4(2):57–62.

    Google Scholar 

  20. Cowan ML, Rosenthal DL, VandenBussche CJ. Improved risk stratification for patients with high-grade urothelial carcinoma following application of the Paris System for Reporting Urinary Cytology. Cancer Cytopathol. 2017;125(6):427–34.

    Google Scholar 

  21. Cowan ML, VandenBussche CJ. The Paris System for Reporting Urinary Cytology: early review of the literature reveals successes and rare shortcomings. J Am Soc Cytopathol. 2018;7(4):185–94.

    Google Scholar 

  22. Wang Y, Auger M, Kanber Y, Caglar D, Brimo F. Implementing The Paris System for Reporting Urinary Cytology results in a decrease in the rate of the “atypical” category and an increase in its prediction of subsequent high-grade urothelial carcinoma. Cancer Cytopathol. 2018;126(3):207–14.

    Google Scholar 

  23. Gutmann EJ. Seminal vesicle cell in a spontaneously voided urine. Diagn Cytopathol. 2006;34(12):824–5.

    Google Scholar 

  24. Koss LG. Errors and pitfalls in cytology of the lower urinary tract. Monogr Pathol. 1997(39):60–74.

    Google Scholar 

  25. Rashidi B, Tongson-Ignacio JE. Melamed-Wolinska bodies in urine cytology an interesting aggregate in a degenerated urothelial cell. Diagn Cytopathol. 2011;39(2):117.

    Google Scholar 

  26. Crabbe JG. “Comet” or “decoy” cells found in urinary sediment smears. Acta Cytol. 1971;15(3):303–5.

    Google Scholar 

  27. Boon ME, van Keep JP, Kok LP. Polyomavirus infection versus high-grade bladder carcinoma. The importance of cytologic and comparative morphometric studies of plastic-embedded voided urine sediments. Acta Cytol. 1989;33(6):887–93.

    Google Scholar 

  28. Herawi M, Parwani AV, Chan T, Ali SZ, Epstein JI. Polyoma virus-associated cellular changes in the urine and bladder biopsy samples: a cytohistologic correlation. Am J Surg Pathol. 2006;30(3):345–50.

    Google Scholar 

  29. Khaled H. Schistosomiasis and cancer in egypt: review. J Adv Res. 2013;4(5):461–6.

    Google Scholar 

  30. Highman W, Wilson E. Urine cytology in patients with calculi. J Clin Pathol. 1982;35(3):350–6.

    Google Scholar 

  31. Rosenthal DL WE, Kurtycz DF. The Paris System for Reporting Urinary Cytology. 1st ed.: Springer; 2015.

    Google Scholar 

  32. Renshaw AA, Nappi D, Weinberg DS. Cytology of grade 1 papillary transitional cell carcinoma. A comparison of cytologic, architectural and morphometric criteria in cystoscopically obtained urine. Acta Cytol. 1996;40(4):676–82.

    Google Scholar 

  33. Kannan V, Bose S. Low grade transitional cell carcinoma and instrument artifact. A challenge in urinary cytology. Acta Cytol. 1993;37(6):899–902.

    Google Scholar 

  34. Bubendorf L, Grilli B, Sauter G, Mihatsch MJ, Gasser TC, Dalquen P. Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings. Am J Clin Pathol. 2001;116(1):79–86.

    Google Scholar 

  35. Cajulis RS, Haines GK, 3rd, Frias-Hidvegi D, McVary K, Bacus JW. Cytology, flow cytometry, image analysis, and interphase cytogenetics by fluorescence in situ hybridization in the diagnosis of transitional cell carcinoma in bladder washes: a comparative study. Diagn Cytopathol. 1995;13(3):214–23; discussion 24.

    Google Scholar 

  36. Lodde M, Mian C, Negri G, Berner L, Maffei N, Lusuardi L, et al. Role of uCyt+ in the detection and surveillance of urothelial carcinoma. Urology. 2003;61(1):243–7.

    Google Scholar 

  37. Muus Ubago J, Mehta V, Wojcik EM, Barkan GA. Evaluation of atypical urine cytology progression to malignancy. Cancer Cytopathol. 2013;121(7):387–91.

    Google Scholar 

  38. Virk RK, Abro S, de Ubago JMM, Pambuccian SE, Quek ML, Wojcik EM, et al. The value of the UroVysion® FISH assay in the risk-stratification of patients with “atypical urothelial cells” in urinary cytology specimens. Diagn Cytopathol. 2017;45(6):481–500.

    Google Scholar 

  39. Ton Nu TN, Kassouf W, Ahmadi-Kaliji B, Charbonneau M, Auger M, Brimo F. The value of the “suspicious for urothelial carcinoma” cytology category: a correlative study of 4 years including 337 patients. Cancer Cytopathol. 2014;122(11):796–803.

    Google Scholar 

  40. Shenoy UA, Colby TV, Schumann GB. Reliability of urinary cytodiagnosis in urothelial neoplasms. Cancer. 1985;56(8):2041–5.

    Google Scholar 

  41. Heymann JJ, Saqi A, Turk AT, Crapanzano J. Micropapillary urothelial carcinoma: Cytologic features in a retrospective series of urine specimens. Cytojournal. 2013;10:4.

    Google Scholar 

  42. Molek KR, Seili-Bekafigo I, Štemberger C, Jonjić N, Đordević G, Duletić-Načinović A. Plasmacytoid urothelial carcinoma--diagnostic challenge in cytology. Diagn Cytopathol. 2013;41(4):369-73.

    Google Scholar 

  43. Dahm P, Gschwend JE. Malignant non-urothelial neoplasms of the urinary bladder: a review. Eur Urol. 2003;44(6):672–81.

    Google Scholar 

  44. Chalasani V, Chin JL, Izawa JI. Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer. Can Urol Assoc J. 2009;3(6 Suppl 4):S193–8.

    Google Scholar 

  45. Zhong M, Gersbach E, Rohan SM, Yang XJ. Primary adenocarcinoma of the urinary bladder: differential diagnosis and clinical relevance. Arch Pathol Lab Med. 2013;137(3):371–81.

    Google Scholar 

  46. Alijo Serrano F, Sánchez-Mora N, Angel Arranz J, Hernández C, Alvarez-Fernández E. Large cell and small cell neuroendocrine bladder carcinoma: immunohistochemical and outcome study in a single institution. Am J Clin Pathol. 2007;128(5):733–9.

    Google Scholar 

  47. Velcheti V, Govindan R. Metastatic cancer involving bladder: a review. Can J Urol. 2007;14(1):3443–8.

    Google Scholar 

  48. Hajdinjak T. UroVysion FISH test for detecting urothelial cancers: meta-analysis of diagnostic accuracy and comparison with urinary cytology testing. Urol Oncol. 2008;26(6):646–51.

    Google Scholar 

  49. Daniely M, Rona R, Kaplan T, Olsfanger S, Elboim L, Zilberstien Y, et al. Combined analysis of morphology and fluorescence in situ hybridization significantly increases accuracy of bladder cancer detection in voided urine samples. Urology. 2005;66(6):1354–9.

    Google Scholar 

  50. Skacel M, Fahmy M, Brainard JA, Pettay JD, Biscotti CV, Liou LS, et al. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology. J Urol. 2003;169(6):2101–5.

    Google Scholar 

  51. Tapia C, Glatz K, Obermann EC, Grilli B, Barascud A, Herzog M, et al. Evaluation of chromosomal aberrations in patients with benign conditions and reactive changes in urinary cytology. Cancer Cytopathol. 2011;119(6):404–10.

    Google Scholar 

  52. Kipp BR, Sebo TJ, Griffin MD, Ihrke JM, Halling KC. Analysis of polyomavirus-infected renal transplant recipients’ urine specimens: correlation of routine urine cytology, fluorescence in situ hybridization, and digital image analysis. Am J Clin Pathol. 2005;124(6):854–61.

    Google Scholar 

  53. Chou R, Gore JL, Buckley D, Fu R, Gustafson K, Griffin JC, et al. Urinary Biomarkers for Diagnosis of Bladder Cancer: A Systematic Review and Meta-analysis. Ann Intern Med. 2015;163(12):922–31.

    Google Scholar 

  54. Black PC, Brown GA, Dinney CP. Molecular markers of urothelial cancer and their use in the monitoring of superficial urothelial cancer. J Clin Oncol. 2006;24(35):5528–35.

    Google Scholar 

  55. Comploj E, Mian C, Ambrosini-Spaltro A, Dechet C, Palermo S, Trenti E, et al. uCyt+/ImmunoCyt and cytology in the detection of urothelial carcinoma: an update on 7422 analyses. Cancer Cytopathol. 2013;121(7):392–7.

    Google Scholar 

  56. Allison DB, VandenBussche CJ. A Review of Urine Ancillary Tests in the Era of the Paris System. Acta Cytol. 2020;64(1-2):182–92.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology and Genomic Medicine, Weill Medical College of Cornell University/Houston Methodist Hospital, Houston, TX, USA

    Haijun Zhou

Authors
  1. Haijun Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Haijun Zhou .

Editor information

Editors and Affiliations

  1. Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX, USA

    Haijun Zhou

  2. Department of Pathology, MD Anderson Cancer Center, Houston, TX, USA

    Charles C. Guo

  3. Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX, USA

    Jae Y. Ro

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Zhou, H. (2021). Urine Cytology. In: Zhou, H., Guo, C.C., Ro, J.Y. (eds) Urinary Bladder Pathology. Springer, Cham. https://doi.org/10.1007/978-3-030-71509-0_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-71509-0_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-71508-3

  • Online ISBN: 978-3-030-71509-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation